On Thyroid Carcinoma
Ali SZ: Thyroid cytopathology: Bethesda and beyond. Acta Cytol 55:4–12, 2011.
Barbet J, Campion L, Kraeber-Bodere F, et al: Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling times in patients with medullary thyroid carcinoma. J Clin Endocrinol Metab 90:6077–6084, 2005.
Bertagna F, Treglia G, Piccardo A, Giubbini R: Diagnostic and Clinical Significance of F-18-FDG-PET/CT Thyroid Incidentalomas. J Clin Endocrinol Metab 97:3866–3875, 2012.
Brown RL, De Sousa J, Cohen EE: Thyroid cancer: Burden of illness and management of disease. J Cancer 2:193–199, 2011.
Cabanillas ME, Hu MI, Durand JB, Busaidy NL: Challenges associated with tyrosine kinase inhibitor therapy for metastatic thyroid cancer. J Thyroid Res 2011:985780, 2011.
Can AS, Peker K: Comparison of palpation-versus ultrasound-guided fine-needle aspiration biopsies in the evaluation of thyroid nodules. BMC Res Notes 1:12, 2008.
Cooper DS, Doherty GM, Haugen BR, et al: Revised American Thyroid Association management guidelines for patients with thyroid dodules and differentiated thyroid cancer. Thyroid 19:1167–1214, 2009.
Garsi JP, Schlumberger M, Rubino C, et al: Therapeutic administration of 131-I for differentiated thyroid cancer: Radiation dose to ovaries and outcome of pregnancies. J Nucl Med 49:845–852, 2008.
Gómez K, Varghese J, Jiménez C: Medullary thyroid carcinoma: molecular signaling pathways and emerging therapies. J Thyroid Res 2011:815826, 2011.
Hall NC, Kloos RT: PET imaging in differentiated thyroid cancer: Where does it fit and how do we use it? Arq Bras Endocrinol Metab 51:793–805, 2007.
Kloos RT, Eng C, Evans DB, et al: Medullary thyroid cancer: Management guidelines of the American Thyroid Association. Thyroid 19:565–612, 2009.
Lassmann M, Reiners C, Luster M: Dosimetry and thyroid cancer: the individual dosage of radioiodine. Endocr Relat Cancer 17:R161–R172, 2010.
Meadows KM, Amdur RJ, Morris CG, et al: External beam radiotherapy for differentiated thyroid cancer. Am J Otolaryngol 27:24–28, 2006.
Sawka AM, Lea J, Alshehri B, et al: A systematic review of the gonadal effects of therapeutic radioactive iodine(Drug information on iodine) in male thyroid cancer survivors. Clin Endocrinol (Oxf) 68:610–617, 2008.
Sherman SI: Advances in chemotherapy of differentiated epithelial and medullary thyroid cancers. J Clin Endocrinol Metab 94:1493–1499, 2009.
Sherman SI: Targeted therapies for thyroid tumores. Mod Pathol 24(suppl)S44–S52, 2011.
Sherman SI: Tyrosine kinase inhibitors and the thyroid. Best Pract Res Clin Endocrinol Metab 23:713–722, 2009.
Sherman SI, Angelos P, Ball DW, et al: Thyroid carcinoma. J Natl Compr Canc Netw 5:568–621, 2007.
Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin 62:10–29, 2012.
Silverberg SJ, Rubin MR, Faiman C, et al: Cincalet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma. J Clin Endocrinol Metab 92:3803–3808, 2007.
United States Nuclear Regulatory Commission: Medical, industrial, and academic uses of nuclear materials: Regulations, guidance, and communications. Available at: www.nrc.gov.
Urhan M, Dadparvar S, Mavi A, et al: Iodine-123 as a diagnostic imaging agent in differentiated thyroid carcinoma: A comparison with iodine-131 post-treatment scanning and serum thyroglobulin measurement. Eur J Nucl Med Mol Imaging 34:1012–1017, 2007.
Verburg FA, de Keizer B, Lips CJ, et al: Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients. Eur J Endocrinol 152:33–37, 2005.
Vianello F, Mazzarotto R, Mian C, et al: Clinical outcome of low-risk differentiated thyroid cancer patients after radioiodine remnant ablation and recombinant human thyroid-stimulating hormone preparation. Clin Oncol (R Coll Radiol) 24:162–168, 2012.
Ying AK, Huh W, Bottomley S, et al: Thyroid cancer in young adults. Semin Oncol 36:258–274, 2009.
On Parathyroid Carcinoma
Fang SH, Lal G: Parathyroid cancer. Endocr Pract 17(suppl 1):36–43, 2011.
Marcocci C, Cetani F, Rubin MR, et al: Parathyroid carcinoma. J Bone Miner Res 23:1869–1880, 2008.
Munson ND, Foote RL, Northcutt RC, et al: Parathyroid carcinoma: Is there a role for adjuvant radiation therapy? Cancer 98:2378–2384, 2003.
Silverberg SJ, Rubin MR, Faiman C, et al: Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma. J Clin Endocrinol Metab 92:3803–3808, 2007.
Siperstein A, Berber E, Mackey R, et al: Prospective evaluation of sestamibi scan, ultrasonography, and rapid PTH to predict the success of limited exploration of sporadic primary hyperparathyroidism. Surgery 136:872–880, 2004.